TXA for GI Bleeds? The HALT-IT Trial

July 15, 2020 00:26:28
TXA for GI Bleeds?  The HALT-IT Trial
Critical Care Perspectives in Emergency Medicine
TXA for GI Bleeds? The HALT-IT Trial

Jul 15 2020 | 00:26:28

/

Show Notes

The use of tranexamic acid (TXA) has markedly increased since the results of the CRASH-II trial were published.  In addition to its use in trauma, TXA has been evaluated and used in numerous other conditions, including post-partum hemorrhage and epistaxis.  Recently, the HALT-IT Trial was published online in the Lancet, which evaluated the use of TXA in patients with acute gastrointestinal bleeding.  In this podcast we discuss the HALT-IT Trial and its implications for clinical practice. 

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

December 31, 2018 00:37:34
Episode Cover

Top Articles of 2018

A plethora of great articles pertaining to the care of critically ill patients were published in 2018.  In this podcast, we review some of...

Listen

Episode 0

June 24, 2019 00:26:09
Episode Cover

Anticoagulation Reversal for ICH

ICH accounts for approximately 15 percent of all strokes.  Despite improvements in neurocritical care, the mortality for patients with ICH can still reach 50...

Listen

Episode

January 27, 2017 00:24:56
Episode Cover

The Complicated Alcohol Withdrawal Patient

Bryan Hayes is back!  In this podcast, we discuss pitfalls in the use of benzodiazpines along with current evidence on adjunctive treatments including propofol,...

Listen